EFFICACITÉ ET TOLÉRABILITÉ DE LA FÉSOTÉRODINE CHEZ LES ENFANTS ATTEINTS DE VESSIE HYPERACTIVE: PHASE D¿EXTENSION.

Registry ID

FOXY2015

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

CHU DE QUÉBEC-UNIVERSITÉ LAVAL

Start date

2015-10-05

Last update

2015-08-18

Conditions

• OVERACTIVE BLADDER

Related clinical trials

• AN INTERNATIONAL PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE (TOLTERODINE)-CONTROLLED MULTICENTER EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF VIBEGRON IN PATIENTS WITH SYMPTOMS OF OVERACTIVE BLADDER
• EFFICIENCY AND TOLERANCE OF FESOTERODIN AND OXYBUTYNIN IN CHILDREN WITH A HYPERACTIVE BLADDER: A COMPARATIVE STUDY
• A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF COMBINATION OF SOLIFENACIN SUCCINATE WITH MIRABEGRON COMPARED TO SOLIFENACIN SUCCINATE AND MIRABEGRON MONOTHERAPY IN SUBJECTS WITH OVERACTIVE BLADDER

View on source registry